Your browser doesn't support javascript.
loading
Sofosbuvir, pegylated interferon, and ribavirin for retreatment of hepatitis C virus genotype 1b following sofosbuvir and ledipasvir failure.
Kalal, Chetan; Shukla, Akash; Mohanka, Ravi; Vora, Mihir; Patel, Priyesh; Shah, Samir.
Affiliation
  • Kalal C; HPB Surgery and Transplantation, Global Institute of Liver Diseases, Mumbai, India.
  • Shukla A; HPB Surgery and Transplantation, Global Institute of Liver Diseases, Mumbai, India.
  • Mohanka R; HPB Surgery and Transplantation, Global Institute of Liver Diseases, Mumbai, India.
  • Vora M; HPB Surgery and Transplantation, Global Institute of Liver Diseases, Mumbai, India.
  • Patel P; HPB Surgery and Transplantation, Global Institute of Liver Diseases, Mumbai, India.
  • Shah S; HPB Surgery and Transplantation, Global Institute of Liver Diseases, Mumbai, India.
Hepatology ; 67(5): 2049-2050, 2018 05.
Article in En | MEDLINE | ID: mdl-29152769

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antiviral Agents / Polyethylene Glycols / Ribavirin / Interferon-alpha / Hepatitis C / Sofosbuvir Limits: Adult / Humans / Male Language: En Journal: Hepatology Year: 2018 Document type: Article Affiliation country: India

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antiviral Agents / Polyethylene Glycols / Ribavirin / Interferon-alpha / Hepatitis C / Sofosbuvir Limits: Adult / Humans / Male Language: En Journal: Hepatology Year: 2018 Document type: Article Affiliation country: India